A new method to enhance effectiveness of cartilage repair therapy
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
A research scientist and internationally recognized authority in the field of blood cell development reflects on 45 years at MIT.
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.
New findings could help engineers design materials for light and heat management.
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
Immunai’s founders were researchers at MIT when they launched their company to help predict how patients will respond to new treatments.
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
Single-cell gene expression patterns in the brain, and evidence from follow-up experiments, reveal many shared cellular and molecular similarities that could be targeted for potential treatment.
Software allows scientists to model shapeshifting proteins in native cellular environments.
Study finds stimulating a key brain rhythm with light and sound increases peptide release from interneurons, driving clearance of an Alzheimer’s protein.
Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.